Sort
51,593 grants matching “hepatitis”
Data Generation Core
$922,805Marc R. Birtwistle · Icahn School Of Medicine At Mount Sinai · U54 · FY2018 · HG
Role of Cyt P450-Mediated Oxidation in Chemical-Induced Toxicity/Carcinogenicity
$922,264Burhan I Ghanayem · Environmental Health Sciences · Z01 · FY2007 · ES
Xenobiotic-Metabolizing Enzymes
$921,928Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Data Generation Core
$921,906Marc R. Birtwistle · Icahn School Of Medicine At Mount Sinai · U54 · FY2016 · HG
Data Generation Core
$921,906Marc R. Birtwistle · Icahn School Of Medicine At Mount Sinai · U54 · FY2015 · HG
Data Generation Core
$921,906Marc R. Birtwistle · Icahn School Of Medicine At Mount Sinai · U54 · FY2019 · HG
Approaches To Immunological Intervention In Schistosomiasis
$921,834Thomas Wynn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs
$921,636Martin H Markowitz · Aaron Diamond Aids Research Center · R01 · FY2013 · DA
Data Generation Core
$921,453Marc R. Birtwistle · Icahn School Of Medicine At Mount Sinai · U54 · FY2017 · HG
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIA
$921,373Margie Clapper · Research Inst Of Fox Chase Can Ctr · N01 · FY2024 · CA
Project 3 - Flavivirus - UTMB
$921,136Pei-Yong Shi · University Of Alabama At Birmingham · U19 · FY2020 · AI
Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs
$920,449Martin H Markowitz · Aaron Diamond Aids Research Center · R01 · FY2016 · DA
Implementation of telemedicine and social network driven HIV service uptake for comprehensive HIV service integration in rural syringe service programs
$920,447Oluwaseun Falade-Nwulia · Johns Hopkins University · R01 · FY2023 · DA
Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms
$919,962Robert C Kaplan · Albert Einstein College Of Medicine · R01 · FY2014 · HL
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)
$918,831David W Crabb · Indiana University Indianapolis · U01 · FY2015 · AA
Cooperative Center for the study of HCV antibody responses and vaccine antigens
$918,736Mansun Law · Scripps Research Institute, The · U19 · FY2017 · AI
KARABELO Clinical Trials Unit for NIAID Networks
$918,589Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2016 · AI
HCV Replication and Immunity
$918,189Christopher M. Walker · Research Inst Nationwide Children'S Hosp · U19 · FY2008 · AI
Transforming Clinical and Translational Research and Education at Rockefeller
$918,000Barry Coller · Rockefeller University · KL2 · FY2008 · RR
Immune Control and Immune Evasion during Acute Hepatitis C Virus Infection
$917,312Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2008 · AI
Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs
$916,984Martin H Markowitz · Aaron Diamond Aids Research Center · R01 · FY2015 · DA
Immunologic and Metabolic Profiles of T cells that control diverse HCV infections
$916,779Andrea L Cox · Johns Hopkins University · U19 · FY2025 · AI
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
$916,147Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Onsite PTSD Treatment to Improve MOUD Outcomes (OPTIMO): a hybrid Type 1 effectiveness-implementation trial of harm reduction PTSD care at syringe service programs
$915,814Teresa Lopez-Castro · City College Of New York · R61 · FY2023 · DA
HCV Replication and Immunity
$915,804Christopher M. Walker · Research Inst Nationwide Children'S Hosp · U19 · FY2006 · AI